ALPN - Alpine Immune Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts4443
Avg. Estimate-0.47-0.5-1.94-2.5
Low Estimate-0.55-0.55-2.1-3.15
High Estimate-0.43-0.47-1.71-1.98
Year Ago EPS-0.7-0.64-2.28-1.94
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts3343
Avg. Estimate380k380k1.13MN/A
Low Estimate250k250kN/AN/A
High Estimate580k580k2.32MN/A
Year Ago Sales50k567k1.74M1.13M
Sales Growth (year/est)660.00%-33.00%-35.10%N/A
Earnings History3/30/20196/29/20199/29/201912/30/2019
EPS Est.-0.69-0.68-0.68-0.58
EPS Actual-0.7-0.64-0.62-0.33
Difference-0.010.040.060.25
Surprise %-1.40%5.90%8.80%43.10%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.47-0.5-1.94-2.5
7 Days Ago-0.47-0.5-1.94-2.5
30 Days Ago-0.47-0.5-1.94-2.5
60 Days Ago-0.55-0.57-2.33-2.55
90 Days Ago-0.55-0.57-2.33-2.55
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALPNIndustrySectorS&P 500
Current Qtr.32.90%N/AN/A-0.34
Next Qtr.21.90%N/AN/A-0.12
Current Year14.90%N/AN/A-0.18
Next Year-28.90%N/AN/A0.26
Next 5 Years (per annum)N/AN/AN/A0.04
Past 5 Years (per annum)N/AN/AN/AN/A